ABSTRACT
Pretransplant autoantibodies to LG3 and angiotensin II type 1 receptors (AT1R) are associated with acute rejection in kidney transplant recipients, whereas antivimentin autoantibodies participate in heart transplant rejection. Ischemia-reperfusion injury (IRI) can modify self-antigenic targets. We hypothesized that ischemia-reperfusion creates permissive conditions for autoantibodies to interact with their antigenic targets and leads to enhanced renal damage and dysfunction. In 172 kidney transplant recipients, we found that pretransplant anti-LG3 antibodies were associated with an increased risk of delayed graft function (DGF). Pretransplant anti-LG3 antibodies are inversely associated with graft function at 1 year after transplantation in patients who experienced DGF, independent of rejection. Pretransplant anti-AT1R and antivimentin were not associated with DGF or its functional outcome. In a model of renal IRI in mice, passive transfer of anti-LG3 IgG led to enhanced dysfunction and microvascular injury compared with passive transfer with control IgG. Passive transfer of anti-LG3 antibodies also favored intrarenal microvascular complement activation, microvascular rarefaction and fibrosis after IRI. Our results suggest that anti-LG3 antibodies are novel aggravating factors for renal IRI. These results provide novel insights into the pathways that modulate the severity of renal injury at the time of transplantation and their impact on long-term outcomes.
Subject(s)
Autoantibodies/blood , Delayed Graft Function/etiology , Graft Survival/immunology , Heparan Sulfate Proteoglycans/immunology , Kidney Transplantation/adverse effects , Reperfusion Injury/etiology , Animals , Autoantibodies/immunology , Delayed Graft Function/blood , Delayed Graft Function/pathology , Female , Follow-Up Studies , Glomerular Filtration Rate , Humans , Kidney Failure, Chronic/surgery , Kidney Function Tests , Male , Mice , Mice, Inbred C57BL , Middle Aged , Prognosis , Reperfusion Injury/blood , Reperfusion Injury/pathology , Retrospective Studies , Risk FactorsABSTRACT
Transplant vasculopathy is associated with neointimal accumulation of recipient-derived mesenchymal stem cells. Increased circulating levels of LG3, a C-terminal fragment of perlecan, were found in renal transplant patients with vascular rejection. Here, we evaluated whether LG3 regulates the migration and homing of mesenchymal stem cells and the accumulation of recipient-derived neointimal cells. Mice were transplanted with a fully-MHC mismatched aortic graft followed by intravenous injection of recombinant LG3. LG3 injections increased neointimal accumulation of α-smooth muscle actin positive cells. When green fluorescent protein (GFP)-transgenic mice were used as recipients, LG3 injection favored accumulation of GFP+ cells to sites of neointima formation. LG3 increased horizontal migration and transmigration of mouse and human MSC in vitro and led to increased ERK1/2 phosphorylation. Neutralizing ß1 integrin antibodies or use of mesenchymal stem cells from α2 integrin-/- mice decreased migration in response to recombinant LG3. Reduced intima-media ratios and decreased numbers of neointimal cells showing ERK1/2 phosphorylation were found in α2-/- recipients injected with recombinant LG3. Collectively, our results suggest that LG3, through interactions with α2ß1 integrins on recipient-derived cells leading to activation of ERK1/2 and increased migration, favors myointimal thickening.
Subject(s)
Graft Rejection/pathology , Heparan Sulfate Proteoglycans/chemistry , Integrin alpha2beta1/metabolism , Mesenchymal Stem Cells/cytology , Neointima/pathology , Vascular Grafting , Animals , Aorta/pathology , Aorta/transplantation , Blood Vessel Prosthesis , Carotid Intima-Media Thickness , Cell Movement , Extracellular Signal-Regulated MAP Kinases/metabolism , Green Fluorescent Proteins/metabolism , Humans , Integrin beta1/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Confocal , Myocytes, Smooth Muscle/cytology , Phenotype , Protein Structure, Tertiary , Rats , Recombinant Proteins/metabolismABSTRACT
The apoptotic program incorporates a paracrine component of importance in fostering tissue repair at sites of apoptotic cell deletion. As this paracrine pathway likely bears special importance in maladaptive intercellular communication leading to vascular remodeling, we aimed at further defining the mediators produced by apoptotic endothelial cells (EC), using comparative and functional proteomics. Apoptotic EC were found to release nanovesicles displaying ultrastructural characteristics, protein markers and functional activity that differed from apoptotic blebs. Tumor susceptibility gene 101 and translationally controlled tumor protein (TCTP) were identified in nanovesicle fractions purified from medium conditioned by apoptotic EC and absent from purified apoptotic blebs. Immunogold labeling identified TCTP on the surface of nanovesicles purified from medium conditioned by apoptotic EC and within multivesicular blebs in apoptotic EC. These nanovesicles induced an extracellular signal-regulated kinases 1/2 (ERK 1/2)-dependent antiapoptotic phenotype in vascular smooth muscle cells (VSMC), whereas apoptotic blebs did not display antiapoptotic activity on VSMC. Caspase-3 biochemical inhibition and caspase-3 RNA interference in EC submitted to a proapoptotic stimulus inhibited the release of nanovesicles. Also, TCTP siRNAs in EC attenuated the antiapoptotic activity of purified nanovesicles on VSMC. Collectively, these results identify TCTP-bearing nanovesicles as a novel component of the paracrine apoptotic program of potential importance in vascular repair.
Subject(s)
Apoptosis , Biomarkers, Tumor/metabolism , Caspase 3/metabolism , Cell Communication , Animals , Endothelial Cells/cytology , Endothelial Cells/enzymology , Endothelial Cells/ultrastructure , Enzyme Activation , Exosomes/ultrastructure , Humans , Nanostructures/ultrastructure , Protein Transport , Rats , Serum , Tumor Protein, Translationally-Controlled 1 , Umbilical Veins/cytologyABSTRACT
The survival of newborns with life-threatening illness has dramatically increased over the past 20 years. Improved obstetrical care, earlier maternal and infant transfer, advanced biomedical technology and improved neonatal intensive care have resulted in decreased mortality and morbidity in this high-risk group. But the need for comprehensive care of high-risk infants extends well beyond their stay in neonatal intensive care units. Infants requiring intensive care at birth are at risk for readmission to hospital and developmental or physical impairment during the early years of life. In addition, the stress of infant illness and caring for an infant with long-term medical or developmental needs can permanently change the family. Thus, the improved survival rate of high-risk newborns has rapidly expanded the support required to meet the complex, multiple and long-term needs of these infants and their families during and after hospitalization.
Subject(s)
Health Services Needs and Demand , Mothers/psychology , Pregnancy, High-Risk/psychology , Social Support , Stress, Psychological/psychology , Adult , Female , Humans , Intensive Care Units, Neonatal , Longitudinal Studies , Pregnancy , Surveys and QuestionnairesABSTRACT
Automobile accidents are one of the leading causes of mortality and morbidity in children. Indeed, the rate is increasing, even though most other causes of child death have decreased in the last five years. The misuse and non-use of child restraints are at the root of this problem.
Subject(s)
Child Welfare , Consumer Product Safety , Infant Equipment/standards , Infant, Premature , Accidents, Traffic/mortality , Accidents, Traffic/statistics & numerical data , Evaluation Studies as Topic , Health Services Needs and Demand , Humans , Infant, NewbornABSTRACT
Kangaroo care is the practice of holding a small, premature infant, naked except for a diaper and hat, against a parent's chest. This skin-to-skin contact resembles how marsupials such as kangaroos and koalas care for their young. Initially established in overcrowded nurseries in developing countries as a substitute for incubators and monitors, kangaroo care is now practised in the neonatal intensive care units of developed countries.